Using Acceptance and Commitment Therapy for Parents of Disabled Child (ACT)

October 15, 2020 updated by: Ecem CICEK GUMUS, Akdeniz University

Effect of Interventions Based on Acceptance and Commitment Therapy Administered to Parents of Special Needs Children on Their Levels of Psychological Resilience, Depression, Anxiety, Stress and Caregiver Burden: A Randomised Controlled Trial

This study was carried out to determine the effect of ACT-based interventions applied to parents of special needs children (CSN) on their levels of psychological inflexibility, psychological resilience, depression, anxiety, stress, and caregiver burden.

Study Overview

Detailed Description

This research is a pretest, posttest, follow-up, randomized controlled experimental study. The research was carried out in Şehitkamil and Şahinbey districts, which are two central districts of Gaziantep Province. 60 parents with disabled children were included in the study (intervention: 30 parents, control: 30 parents). The research data was collected as pretest, posttest and follow-up test from the intervention group between April and December 2019, and the control group between April and September 2019 in three stages. Parental Identification Form, Acceptance and Action Questionnaire (AAQ-II), Depression, Anxiety and Stress Scale (DASS-21), Adult Psychological Resilience Scale (RSA-21) were used as data collection form. After the pre-test data was collected, the Acceptance and Commitment Therapy Based Intervention Program was applied to the intervention group in six sessions. The duration of each session lasted on average 60-90 minutes. A session was held for each parent once a week. The control group participated in the training carried out by the guidance service.

The intervention programme based on ACT was prepared with the aim of reducing levels of psychological inflexibility, caregiver burden, depression, anxiety and stress, and of increasing levels of psychological resilience in parents of CSN.

In the preparation of the interventions and planning of the sessions based on ACT, the researcher utilised studies in the literature and the basic ACT training she had received. After preparation of the ACT intervention protocol, it was given its final shape by obtaining the views of specialists working in this field. The sessions were prepared based on six components of psychological flexibility found at the basis of ACT.

Keywords: Acceptance and commitment therapy (ACT), special needs child, psychological inflexibility, resilience, depression-anxiety-stress levels, caregiver burden, public health nurse.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • University Boulevard
      • Gaziantep, University Boulevard, Turkey, 27310
        • Gaziantep University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Parents with children at the Gaziantep Private Education Practice Schools I. and II. stage (the mother or father will be the person who is primarily responsible for the child's care).
  • Those living in the central districts of Gaziantep province,
  • Those who have not received any such training (ACT) or received any psychiatric treatment/support or therapy,
  • There is currently no ongoing psychological or psychiatric treatment,
  • Does not have problems such as substance/alcohol addiction,
  • Without communication disabilities (hearing and speaking),
  • Speaking Turkish,
  • Literate,
  • Parents who agreed to participate in the research

Exclusion Criteria:

  • Parents with cognitive impairment (mental retardation or a psychiatric diagnosis),
  • Parents who have previously received psychiatric support or therapy,
  • Parents with problems such as substance/alcohol abuse,
  • Has a communication disability (hearing-speaking),
  • Using a language other than Turkish,
  • Illiterate parents

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
''Acceptance and Commitment Therapy Based Intervention Program was applied to the intervention group
The Acceptance and Commitment Therapy Based Intervention Program was applied to the intervention group in six sessions. The duration of each session lasted on average 60-90 minutes. A session was held for each parent once a week.
No Intervention: Control group
Only data collection was carried out. No attempt was made by the researcher during the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptance and Action Questionnaire (AAQ-II)
Time Frame: 8 months
The Acceptance and Action Questionnaire consists of 7 items and evaluates information about psychological consistency. the minimum and maximum values of scale changes between 7 and 49 points. Interpretation of score for scale; the high total score obtained from the scale shows that the level of "psychological consistency" is also high.
8 months
Depression, Anxiety and Stress Scale (DASS-21)
Time Frame: 8 months

The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress.

Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content. The depression scale assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest / involvement, anhedonia and inertia. The anxiety scale assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The stress scale is sensitive to levels of chronic non-specific arousal. It assesses difficulty relaxing, nervous arousal, and being easily upset / agitated, irritable / over-reactive and impatient. Scores for depression, anxiety and stress are calculated by summing the scores for the relevant items.

8 months
Adult Psychological Resilience Scale (RSA-21)
Time Frame: 8 months
The Adult Psychological Resilience Scale consists of 21 items and evaluates information about psychological resilience. Minimum 21 points and maximum 105 points are obtained from the scale. The high total score obtained from the scale indicates that the level of "psychological resilience" is high.
8 months
The Zarit Burden Scale
Time Frame: 9 months
The Zarit Burden Interview consists of 22 items and evaluates information about caregiver burden.Interpretation of Score: 0 - 21 little or no burden, 21 - 40 mild to moderate burden, 41 - 60 moderate to severe burden, 61 - 88 severe burden. The higher the score obtained, the higher the burden level
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

April 1, 2019

Study Completion (Actual)

December 20, 2019

Study Registration Dates

First Submitted

March 10, 2020

First Submitted That Met QC Criteria

March 12, 2020

First Posted (Actual)

March 13, 2020

Study Record Updates

Last Update Posted (Actual)

October 19, 2020

Last Update Submitted That Met QC Criteria

October 15, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • TDK-2019-4588

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Acceptance and Commitment Therapy

Subscribe